GlassScriptPhysician profile
Judith A Rippert
NPI 1871563114
$750.19
in general payments reported to CMS, 2019-2025
13 companies · $189 in 2025
The $189 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $331 · 2020: $62.30 · 2024: $168 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $357.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $178.60 | 2024-2025 | |
| Medtronic, INC. | $142.97 | 2025 | Linq II |
| Amgen INC. | $115.68 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $70.68 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $65.61 | 2019-2024 | Lifevest |
| Gilead Sciences, INC. | $54.53 | 2019 | |
| Sanofi-Aventis U.S. LLC | $28.42 | 2019 | |
| Amarin Pharma, INC. | $27.99 | 2019 | |
| Abbott Laboratories | $17.03 | 2024 | Gallant |
| Pfizer INC. | $12.68 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.60 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.42 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $10.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Rippert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.